
Overview
MSD Polska is part of a global biopharmaceutical company that conducts research and develops therapies for people and animals. It works on cancer medicines, vaccines and antibiotics targeting drug-resistant bacteria, and partners with Polish research centers and public institutions.
Financials
Revenue history (in m)
From the notes
| Current income tax (CIT due) | $1,039,601 | |
| Profit allocation | Retained in reserve capital | |
| Events after the balance sheet date | Yes | |
| Parent company | MSD Human Health Holding B.V. |
Filing timeliness
Financial statements were filed on time, on average 92 days early. All were audited by a statutory auditor.
- 202526/05/2026
- 202416/05/2025
- 202330/04/2024
- 202205/05/2023
- 202109/05/2022
- 202002/03/2021
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.
Results vs industry
Industry
- Advertising agencies (73.11.Z) Primary
Websites
The company has 6 websites. Most of them run on WordPress. The company uses the Meta advertising pixel (Facebook, Instagram).
- msd.plHome – MSD PolskaWordPressGoogle Tag ManagerYoast SEONginx
- hpv.plHPV | szczepienia przeciw HPV dla dzieci i dorosłychWordPress 7.1ElementorGoogle Tag ManagerMeta PixelYoast SEOLLiteSpeed
- mojawstazka.plStrona główna – portal onkologiczny | Moja Wstążka
Trademarks
The company currently holds no active trademarks with the Polish Patent Office. 2 marks have expired or were not registered. The first mark was filed in 2006.
| Mark | Protected until | |
|---|---|---|
| ZADBAJ O ŻYCIE - ZASZCZEP SIĘ PRZECIWKO RAKOWI SZYJKI MACICY (word) | – | |
| Chronię życie przed rakiem szyjki macicy www.hpv.pl | – |
Authorized Representatives
Manner of representation
Each member of the management board independently.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Msd Human Health Holding B.v. | 12,120 | $1,636,953.00 | 100% |
Beneficial owners
| Person | Rights |
|---|---|
Capital group
The company belongs to the Merck & CO., Inc. (United States) group. Its direct owner is MSD Human Health Holding B.V. (Netherlands). The group has 24 companies, 22 of them abroad.
| Name | Country |
|---|---|
| Allflex India Private Limited | |
| Intervet India Private Limited | |
| Merck Global Health Innovation Fund, LLC | |
| Merck Holdings LLC | |
| Merck International Holdings LLC |
Bank accounts
Registered as a VAT taxpayer on 2004-02-18.
67 1030 1508 0000 0005 0365 7007
23 1030 1508 0000 0005 0365 7023
98 1030 1508 0000 0005 0365 7031
Debt
No entries in the National Debtors Register (KRZ).
Real estate
| Type | Amount |
|---|---|
Buildings and premises | PLN 1.3MPLN 1,283,880 |
MSiG notices
| Publication date | Event | |
|---|---|---|
| Apr 13, 2011 | Merger registered | |
| Jan 17, 2011 | Merger plan |
Public aid
No public aid cases recorded in the last 10 years.
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Astrazeneca Pharma Poland sp. z o.o. | $466,142,370.29 | astrazeneca.pl | ||
| Takeda Pharma sp. z o.o. | $246,400,594.27 | takeda.com | ||
| Tarchomińskie Zakłady Farmaceutyczne Polfa S.A. | $102,988,448.02 | polfa-tarchomin.com.pl | ||
| Przedsiębiorstwo Farmaceutyczne Lek-Am sp. z o.o. | $102,266,019.67 | lekam.pl | ||
| Teva Pharmaceuticals Polska sp. z o.o. | $97,284,137.57 | teva.pl | ||
| Sandoz Polska sp. z o.o. | $89,136,265.74 | sandoz.com | ||
| Chiesi Poland sp. z o.o. | $87,762,158.97 | chiesi.com | ||
| Synoptis Pharma sp. z o.o. | $79,311,000.88 | synoptispharma.pl | ||
| Solinea sp. z o.o. | $72,245,607.27 | solinea.pl | ||
| Celon Pharma S.A. | $51,765,221.75 | celonpharma.com |
Change history
| Date | Event | |
|---|---|---|
| 2017-07-27 | PKD change (Removed: 46.18.Z, 46.46.Z, 73.12.C, 77.33.Z, 77.39.Z) | |
| 2011-03-31 | Share capital increase (6,050,000.00 PLN → 6,060,000.00 PLN) | |
| 2011-03-31 | Switch to PKD 2007 (10 PKD 2004 codes → 15 PKD 2007 codes) | |
| 2005-01-04 | Address change (Puławska 303, 02-785, Warszawa → Chłodna 51, 00-867, Warszawa) | |
| 2004-09-15 | Share capital increase (50,000.00 PLN → 6,050,000.00 PLN) |
FAQ
Last updated: 2026-10-07